Clinic
Hattiesburg Clinic PA
Hattiesburg Clinic PA was paid $59.36M by Medicaid between Jan 2018 and Dec 2024, across 434 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.
33Billing provider infoHATTIESBURG CLINIC PA
HATTIESBURG, MS 39401
HATTIESBURG, MS 39401
33aNPI1740213446assigned 07/08/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$59.36M
24GClaims2,245,468
24DCodes billed434
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Mississippi
Rank by total paid#1 of 18
Median peer was paid$46K
This provider vs. median1,297×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BATSON, BRYAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 265,498 | $8.25M | |
| 2019 | 315,031 | $9.91M | |
| 2020 | 269,325 | $8.69M | |
| 2021 | 295,326 | $10.10M | |
| 2022 | 527,277 | $8.92M | |
| 2023 | 355,922 | $8.08M | |
| 2024incomplete | 217,089 | $5.41M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 296,715 | 258,042 | $14.84M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 334,037 | 279,706 | $13.94M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.2% | 71,302 | 27,152 | $1.90M |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 2.8% | 5,205 | 4,261 | $1.69M |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 1.9% | 21,751 | 20,405 | $1.13M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.7% | 1,957 | 1,230 | $1.00M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.6% | 20,079 | 18,560 | $963K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 17,133 | 14,976 | $831K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 8,070 | 7,323 | $805K |
| 59426 | 1.3% | 10,177 | 6,689 | $789K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 13,406 | 11,266 | $772K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 19,766 | 17,919 | $765K |
422 more codes
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.1% | 11,679 | $663K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.0% | 8,814 | $612K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 6,819 | $576K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 16,562 | $537K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 4,144 | $528K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 9,212 | $503K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 5,712 | $445K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 19,248 | $425K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 3,952 | $421K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 4,885 | $418K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 2,472 | $400K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 11,419 | $382K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 9,251 | $373K |
| 95811 | <1% | 1,263 | $362K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 5,454 | $359K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,611 | $333K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,161 | $331K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 20,248 | $315K |
| 92015 | Determination of refractive state | <1% | 17,647 | $300K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 6,177 | $295K |
| 92523 | <1% | 2,035 | $295K | |
| 59425 | <1% | 3,869 | $287K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 3,646 | $276K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 1,713 | $272K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 9,572 | $266K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 19,901 | $258K |
| 99219 | <1% | 4,192 | $251K | |
| 99223 | Prolong inpt eval add15 m | <1% | 4,945 | $249K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,510 | $243K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 20,657 | $238K |
| 96130 | <1% | 3,719 | $236K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 7,611 | $232K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,728 | $225K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 11,482 | $224K |
| 99243 | <1% | 2,590 | $216K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 4,089 | $201K |
| 99242 | <1% | 3,297 | $197K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,437 | $184K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,252 | $174K |
| 94010 | <1% | 11,752 | $167K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 43,241 | $162K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12,898 | $161K |
| 96131 | <1% | 3,378 | $158K | |
| 76820 | <1% | 4,872 | $151K | |
| 90961 | <1% | 3,248 | $151K | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 81 | $151K |
| 76825 | <1% | 940 | $148K | |
| 96137 | <1% | 3,563 | $135K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 8,411 | $134K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,735 | $134K |
| 99490 | Ccm add 20min | <1% | 16,907 | $134K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,657 | $129K |
| 88307 | <1% | 2,280 | $122K | |
| 20610 | <1% | 6,481 | $122K | |
| 88304 | <1% | 5,782 | $120K | |
| V2020 | Frames, purchases | <1% | 5,541 | $116K |
| 17110 | <1% | 1,632 | $115K | |
| 93000 | <1% | 19,909 | $114K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 77,471 | $111K |
| 01961 | <1% | 455 | $107K | |
| 99051 | <1% | 8,603 | $103K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 10,513 | $100K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,371 | $96K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 522 | $95K |
| 87634 | <1% | 2,537 | $95K | |
| 96127 | <1% | 24,737 | $86K | |
| 36902 | <1% | 1,179 | $86K | |
| 96136 | <1% | 3,746 | $82K | |
| 11730 | <1% | 1,370 | $75K | |
| 99220 | <1% | 1,244 | $75K | |
| 96101 | <1% | 841 | $70K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,083 | $68K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 880 | $65K |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | <1% | 366 | $65K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 675 | $61K |
| 00126 | <1% | 744 | $60K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 245 | $58K |
| 86738 | <1% | 4,522 | $58K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 923 | $53K |
| 92567 | <1% | 4,802 | $50K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,801 | $50K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 386 | $50K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 1,019 | $49K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 3,541 | $48K |
| 93015 | <1% | 702 | $47K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,091 | $46K |
| 88312 | <1% | 1,052 | $45K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 4,664 | $45K |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 3,044 | $44K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,133 | $44K |
| 92002 | <1% | 726 | $43K | |
| 93923 | <1% | 1,325 | $43K | |
| 99442 | <1% | 2,460 | $40K | |
| 92557 | <1% | 1,810 | $39K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,945 | $39K |
| 99307 | <1% | 6,349 | $39K | |
| 85004 | <1% | 7,745 | $38K | |
| 95117 | <1% | 4,286 | $37K | |
| 37227 | <1% | 48 | $37K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 177 | $37K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 292 | $34K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 961 | $34K |
| 99241 | <1% | 1,008 | $33K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 875 | $32K |
| 88112 | <1% | 2,156 | $32K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,689 | $31K |
| 99441 | <1% | 1,459 | $29K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 693 | $28K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,605 | $28K |
| 99217 | <1% | 1,555 | $27K | |
| 76775 | <1% | 1,015 | $26K | |
| 73562 | <1% | 1,476 | $26K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 330 | $26K |
| 96161 | <1% | 2,040 | $25K | |
| 95874 | <1% | 869 | $23K | |
| 0001A | <1% | 1,120 | $23K | |
| 0002A | <1% | 967 | $22K | |
| 97161 | <1% | 870 | $22K | |
| 78431 | <1% | 217 | $22K | |
| 11056 | <1% | 1,315 | $21K | |
| 00910 | <1% | 514 | $20K | |
| 64616 | <1% | 173 | $20K | |
| 96401 | <1% | 800 | $19K | |
| 94729 | <1% | 827 | $19K | |
| 92551 | <1% | 1,658 | $19K | |
| 78492 | <1% | 54 | $19K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 734 | $19K |
| 64615 | <1% | 201 | $18K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,880 | $18K |
| 00142 | <1% | 625 | $18K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 108 | $17K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,431 | $17K |
| 76641 | <1% | 367 | $17K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 3,531 | $16K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 159 | $16K |
| 90686 | <1% | 6,371 | $16K | |
| 80305 | <1% | 3,696 | $16K | |
| 92552 | <1% | 844 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,584 | $15K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,644 | $15K |
| 94726 | <1% | 789 | $15K | |
| 99205 | Prolong outpt/office vis | <1% | 244 | $14K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 4,192 | $14K |
| 73630 | <1% | 1,111 | $14K | |
| 11720 | <1% | 3,165 | $13K | |
| 74018 | <1% | 987 | $13K | |
| 99443 | <1% | 466 | $13K | |
| J0897 | Injection, denosumab, 1 mg | <1% | 219 | $12K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 324 | $12K |
| 99255 | <1% | 88 | $12K | |
| 99173 | <1% | 2,530 | $12K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 127 | $12K |
| 20611 | <1% | 483 | $12K | |
| 86308 | <1% | 2,721 | $12K | |
| 92083 | <1% | 329 | $12K | |
| 90677 | <1% | 1,016 | $12K | |
| 93325 | <1% | 938 | $12K | |
| 95886 | <1% | 266 | $11K | |
| 64493 | <1% | 190 | $11K | |
| 81001 | <1% | 11,511 | $11K | |
| 99050 | <1% | 917 | $10K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,512 | $10K |
| 99218 | <1% | 186 | $10K | |
| 94060 | <1% | 241 | $10K | |
| 69210 | <1% | 477 | $9K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 101 | $9K |
| 85018 | <1% | 5,918 | $9K | |
| 81003 | <1% | 11,199 | $9K | |
| 31575 | <1% | 217 | $8K | |
| 59410 | <1% | 62 | $8K | |
| 71250 | <1% | 353 | $8K | |
| 70486 | <1% | 107 | $8K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,107 | $8K |
| 77065 | Tomosynthesis, mammo | <1% | 286 | $8K |
| 90682 | <1% | 793 | $8K | |
| 99254 | <1% | 67 | $7K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 191 | $7K |
| 72141 | <1% | 64 | $7K | |
| 88342 | <1% | 277 | $6K | |
| 81025 | <1% | 1,530 | $6K | |
| 51798 | <1% | 2,009 | $6K | |
| 64483 | <1% | 82 | $6K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 181 | $6K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 902 | $6K |
| 00731 | <1% | 174 | $6K | |
| 73564 | <1% | 368 | $6K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 50 | $6K |
| 88302 | <1% | 778 | $6K | |
| 37229 | <1% | 13 | $5K | |
| 11721 | <1% | 730 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,416 | $5K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 71 | $5K |
| 86003 | <1% | 33 | $5K | |
| 95115 | <1% | 709 | $5K | |
| 96112 | <1% | 31 | $4K | |
| 85651 | <1% | 2,794 | $4K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 17 | $4K |
| 86140 | <1% | 2,299 | $4K | |
| 87081 | <1% | 661 | $4K | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | <1% | 210 | $4K |
| 62323 | <1% | 39 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 151 | $4K |
| 93312 | <1% | 85 | $4K | |
| 64494 | <1% | 181 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 341 | $4K |
| 90715 | <1% | 665 | $4K | |
| 99407 | <1% | 814 | $4K | |
| 78434 | <1% | 266 | $4K | |
| 99460 | <1% | 41 | $4K | |
| 96367 | <1% | 433 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 397 | $3K |
| 83655 | <1% | 271 | $3K | |
| V2101 | Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens | <1% | 93 | $3K |
| 80061 | Lipid panel | <1% | 252 | $3K |
| 64495 | <1% | 141 | $3K | |
| 87631 | <1% | 492 | $3K | |
| 99221 | <1% | 277 | $3K | |
| L1812 | Knee orthosis, elastic with joints, prefabricated, off-the-shelf | <1% | 124 | $3K |
| 97597 | <1% | 459 | $3K | |
| 0004A | <1% | 145 | $3K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 138 | $3K |
| 99318 | <1% | 160 | $3K | |
| 0071A | <1% | 138 | $3K | |
| 87807 | <1% | 270 | $3K | |
| 93297 | <1% | 245 | $3K | |
| 99406 | <1% | 674 | $3K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 330 | $3K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 32 | $3K |
| 99305 | <1% | 41 | $3K | |
| 00813 | <1% | 86 | $3K | |
| 85027 | <1% | 800 | $2K | |
| 72100 | <1% | 280 | $2K | |
| 92136 | <1% | 567 | $2K | |
| 73130 | <1% | 230 | $2K | |
| 76813 | <1% | 38 | $2K | |
| 93880 | <1% | 164 | $2K | |
| 0072A | <1% | 83 | $2K | |
| 73610 | <1% | 210 | $2K | |
| 92250 | <1% | 118 | $2K | |
| 99152 | <1% | 1,174 | $2K | |
| 0054A | <1% | 66 | $2K | |
| 66821 | <1% | 44 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,573 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 79 | $2K |
| 75574 | <1% | 14 | $2K | |
| 95012 | <1% | 122 | $2K | |
| 96417 | <1% | 53 | $2K | |
| 76937 | <1% | 327 | $2K | |
| 87210 | <1% | 685 | $2K | |
| 73030 | <1% | 427 | $2K | |
| 99462 | <1% | 52 | $2K | |
| 73110 | <1% | 127 | $2K | |
| 99381 | <1% | 18 | $2K | |
| 11102 | <1% | 93 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 48 | $2K |
| 75635 | <1% | 13 | $2K | |
| 99349 | <1% | 18 | $2K | |
| 97802 | <1% | 84 | $1K | |
| 92556 | <1% | 86 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 54 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 54 | $1K |
| 76536 | <1% | 71 | $1K | |
| 36620 | <1% | 218 | $1K | |
| 00840 | <1% | 25 | $1K | |
| 88311 | <1% | 314 | $1K | |
| 01400 | <1% | 22 | $1K | |
| 11100 | <1% | 30 | $1K | |
| 0031A | <1% | 57 | $1K | |
| 93296 | <1% | 194 | $1K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 2,865 | $1K |
| 96111 | <1% | 18 | $1K | |
| 99284 | Emergency room visit (serious) | <1% | 12 | $1K |
| 29075 | <1% | 35 | $1K | |
| 76801 | <1% | 13 | $1K | |
| 20553 | <1% | 51 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,201 | $1K |
| 76770 | <1% | 13 | $986.69 | |
| 00790 | <1% | 52 | $957.63 | |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 24 | $955.21 |
| 73140 | <1% | 44 | $940.76 | |
| 90732 | <1% | 25 | $923.97 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 19 | $902.86 |
| 01480 | <1% | 24 | $885.50 | |
| 93295 | <1% | 59 | $859.29 | |
| 17000 | <1% | 171 | $807.30 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 73 | $728.88 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 67 | $726.20 |
| 90670 | <1% | 3,525 | $691.11 | |
| 43235 | <1% | 16 | $670.97 | |
| 73502 | <1% | 138 | $670.38 | |
| 94664 | <1% | 130 | $667.76 | |
| 82044 | <1% | 294 | $661.66 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 28 | $655.23 |
| 99402 | <1% | 12 | $653.88 | |
| 36556 | <1% | 19 | $622.42 | |
| 01968 | <1% | 18 | $598.34 | |
| 93320 | <1% | 86 | $550.66 | |
| 00851 | <1% | 20 | $506.87 | |
| 73560 | <1% | 165 | $504.02 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 338 | $470.69 |
| 72110 | <1% | 13 | $445.69 | |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | <1% | 40 | $406.65 |
| 92133 | <1% | 51 | $381.83 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,094 | $375.65 |
| 90656 | <1% | 347 | $372.11 | |
| 0124A | <1% | 110 | $361.90 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 33 | $359.11 |
| 85060 | <1% | 40 | $347.10 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 687 | $345.55 |
| 64455 | <1% | 13 | $341.51 | |
| 96523 | <1% | 99 | $334.41 | |
| 36416 | <1% | 3,516 | $333.86 | |
| 73120 | <1% | 58 | $316.54 | |
| 96415 | <1% | 172 | $312.47 | |
| 99496 | <1% | 12 | $298.18 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 377 | $282.59 |
| 96380 | <1% | 16 | $275.57 | |
| 75710 | <1% | 14 | $270.32 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 24 | $258.00 |
| 93458 | <1% | 23 | $257.83 | |
| 97113 | <1% | 64 | $250.44 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 50 | $250.05 |
| D1206 | Topical application of fluoride varnish | <1% | 12 | $249.87 |
| 90461 | <1% | 495 | $249.60 | |
| 64450 | <1% | 22 | $246.90 | |
| 95251 | <1% | 77 | $237.79 | |
| 76942 | <1% | 100 | $231.83 | |
| 11055 | <1% | 26 | $231.41 | |
| 90651 | <1% | 187 | $231.35 | |
| 0012A | <1% | 22 | $224.25 | |
| 01810 | <1% | 30 | $222.81 | |
| 93298 | <1% | 46 | $207.07 | |
| 82785 | <1% | 12 | $199.39 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 82 | $196.74 |
| 97016 | <1% | 21 | $173.09 | |
| 85379 | <1% | 33 | $165.04 | |
| 0011A | <1% | 22 | $160.82 | |
| 74420 | <1% | 25 | $155.16 | |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 42 | $147.74 |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 22 | $141.56 |
| 93971 | <1% | 21 | $140.64 | |
| 99497 | <1% | 14 | $136.00 | |
| 00811 | <1% | 14 | $111.31 | |
| 90662 | <1% | 1,395 | $103.90 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 150 | $103.66 |
| 99001 | <1% | 362 | $101.04 | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 22 | $98.64 |
| 84439 | <1% | 14 | $96.37 | |
| 90680 | <1% | 1,508 | $91.15 | |
| 90723 | <1% | 2,267 | $88.87 | |
| 99348 | <1% | 15 | $88.83 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 415 | $87.17 |
| 73521 | <1% | 57 | $74.86 | |
| 82950 | <1% | 23 | $71.33 | |
| 96160 | <1% | 104 | $67.30 | |
| 99225 | <1% | 27 | $62.36 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 472 | $62.25 |
| 85610 | <1% | 318 | $55.12 | |
| 17003 | <1% | 95 | $54.50 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 177 | $51.04 |
| 90648 | <1% | 1,663 | $35.06 | |
| 82962 | <1% | 34 | $31.60 | |
| 82565 | <1% | 13 | $27.43 | |
| 3074F | <1% | 109,491 | $26.28 | |
| 93294 | <1% | 13 | $25.76 | |
| 73620 | <1% | 28 | $22.71 | |
| 84520 | <1% | 13 | $21.17 | |
| 84550 | <1% | 52 | $16.40 | |
| 3075F | <1% | 18,550 | $14.31 | |
| 3008F | <1% | 189,200 | $13.89 | |
| 88341 | <1% | 15 | $11.68 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 325 | $5.80 |
| 3077F | <1% | 21,345 | $1.93 | |
| 1159F | <1% | 37,022 | $1.27 | |
| 90633 | <1% | 737 | $0.01 | |
| 3078F | 0% | 113,185 | $0.00 | |
| 1160F | 0% | 37,001 | $0.00 | |
| 0502F | 0% | 15,677 | $0.00 | |
| 2022F | 0% | 115 | $0.00 | |
| 3046F | 0% | 141 | $0.00 | |
| 90671 | 0% | 659 | $0.00 | |
| 90681 | 0% | 60 | $0.00 | |
| 90734 | 0% | 139 | $0.00 | |
| 90380 | 0% | 78 | $0.00 | |
| 90700 | 0% | 134 | $0.00 | |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 60 | $0.00 |
| 90710 | 0% | 195 | $0.00 | |
| 2028F | 0% | 27 | $0.00 | |
| 77062 | 0% | 61 | $0.00 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 55 | $0.00 |
| 90707 | 0% | 148 | $0.00 | |
| 3051F | 0% | 225 | $0.00 | |
| 97803 | 0% | 38 | $0.00 | |
| 99499 | 0% | 21 | $0.00 | |
| 00300 | 0% | 14 | $0.00 | |
| 90647 | 0% | 1,017 | $0.00 | |
| 3079F | 0% | 28,589 | $0.00 | |
| 90696 | 0% | 228 | $0.00 | |
| 1125F | 0% | 3,135 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 2,750 | $0.00 |
| 3080F | 0% | 9,423 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 1,530 | $0.00 |
| 0500F | 0% | 918 | $0.00 | |
| 1126F | 0% | 2,775 | $0.00 | |
| 1111F | 0% | 1,950 | $0.00 | |
| 1170F | 0% | 208 | $0.00 | |
| 3351F | 0% | 1,099 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 187 | $0.00 |
| 3044F | 0% | 1,108 | $0.00 | |
| 99439 | 0% | 29 | $0.00 | |
| 3353F | 0% | 14 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 291 | $0.00 |
| 3052F | 0% | 70 | $0.00 | |
| 90716 | 0% | 107 | $0.00 | |
| 0503F | 0% | 43 | $0.00 | |
| 20550 | 0% | 30 | $0.00 | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 0% | 13 | $0.00 |
| 2023F | 0% | 15 | $0.00 | |
| 90381 | 0% | 134 | $0.00 | |
| 99495 | 0% | 100 | $0.00 | |
| 3072F | 0% | 27 | $0.00 | |
| 77001 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBATSON, BRYAN (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Hattiesburg Clinic PA | Hattiesburg, MS | $10.82M |
| Hattiesburg Clinic PA | Hattiesburg, MS | $7.93M |
| Lowery A. Woodall Outpatient Surgery Facility, LLC | Hattiesburg, MS | $6.14M |
| Hattiesburg Clinic, PA | Hattiesburg, MS | $5.28M |
| Hattiesburg Clinic PA | Hattiesburg, MS | $3.35M |
| Hattiesburg Clinic PA | Hattiesburg, MS | $2.81M |
| Hattiesburg Clinic, PA | Laurel, MS | $2.56M |
| Hattiesburg Clinic PA | Hattiesburg, MS | $2.41M |
| Hattiesburg Clinic, PA | Columbia, MS | $2.41M |
| Hattiesburg Clinic, PA | Waynesboro, MS | $1.29M |
| Hattiesburg Clinic, PA | Bay Springs, MS | $1.22M |
| Hattiesburg Clinic, PA | Picayune, MS | $1.14M |
| Hattiesburg Clinic, PA | Collins, MS | $1.11M |
| Hattiesburg Clinic, PA | Hattiesburg, MS | $877K |
| Hattiesburg Clinic, P.A. | Pachuta, MS | $614K |
| Hattiesburg Clinic, P.A | Silver Creek, MS | $502K |
| Hattiesburg Clinic, PA | Richton, MS | $485K |
| Hattiesburg Clinic, PA | Tylertown, MS | $328K |
| Hattiesburg Clinic, PA | Wiggins, MS | $228K |
| Hattiesburg Clinic PA | Petal, MS | $39K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.